Referenser
- Badía-Flores J., García-Rubio R., Muñoz Bar-Radas F. Efecto sintomatico y tolerabilidad del diclofenac sódico en la artritis reumatoide. Invest Méd Int(Mex) 1975; 2: 194
- Bracharz H., Laas H. Langzeitverträglichkeit von Voltaren bei degenerativen Gelenkerkrankungen unter besonderer Berücksichtigung klinisch-chemischer Parameter. Therapiewoche 1976; 26: 2993
- Ciccolunghi S. N., Chaudri H. A. Results of worldwide clinical trials with Voltaren. Chronic Forms of Polyarthritis, F. J. Wagenhäuser. International Symposium, Torremolinos, Huber, Berne, Stuttgart and Vienna 1975; 345, 1976
- Ciccolunghi S. N., Chaudri H. A., Schubiger B. I. Long-term trials in rheumatic indications–a series of compromises. Eular Bull Monograph Series No. 1, 1977; 135
- Co-operating Clinics Committee of the American Rheumatism Association. A seven-day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum 1965; 8: 302
- Dürrigl T., Vitaus M., Pucar I., Miko M. Diclofenac sodium (Voltaren): results of a multi-centre comparative trial in adult-onset rheumatoid arthritis. J Int Med Res 1975; 3: 139
- Eberl R., Tausch G., Siegmeth W. Results of clinical trials with Voltaren in rheumatic diseases. 335, loc. cit.3
- Houli J., Klein B., Coimbra F. A. Efficacy and tolerability of Voltaren (diclofenac sodium GP 45,840) in rheumatoid arthritis. Folha Méd (Rio de Janeiro) 1975; 71: 685
- Joubert P. H., Kushlick A. R., McNeill W. G., Sheard E. S. C., Müller F. O. South African multicentre trial with Voltaren in osteo-arthritis of the knee. S Afr Med J 1974; 48: 1973
- Kirchheiner B., Trang L., Wollheim F. A. Diclofenac sodium (Voltaren) in rheumatoid arthritis: a double-blind comparison with indomethacin and placebo. Int J Clin Pharmacol Biopharm 1976; 13: 292
- Krupp P. J., Exer B., Menassé-Gdynia R., Ziel R. Neue Aspekte der Entzündungshemmung durch nicht-steroide Antiphlogistika. Wirkung von Voltaren: Schweiz Med Wochenschr 1975; 105: 646
- Krupp P. J., Menassé-Gdynia R., Sallmann A., Wilhelmi G., Ziel R., Jaques R. Sodium [o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate (GP 45840), a new non-steroidal anti-inflammatory agent. Experi-entia 1973; 29: 450
- Lehtola J., Sipponen P. A gastroscopic and histological double-blind study of the effects of diclofenac sodium and naproxen on the human gastric mucosa. Scand J Rheumatol 1977; 6: 97
- Meyers O. L., Quantock O. P., Joubert P. G., Louw D. F. du P., Marais D. F., McScott W. A. D., Müller F. O. A multicentre trial of Voltaren in the treatment of rheumatoid arthritis. S Afr Med J 1974; 45: 2013
- Miura T. Long-term tolerability study of Voltaren. J Int Med Res 1975; 3: 145
- Ropes M. W., Bennett G. A., Cobbs S., Jacox R., Jessar R. A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum 1959; 2: 16
- Rossi F. A., Baroni L. A double-blind comparison between diclofenac sodium and ibuprofen in osteoarthritis. J Int Med Res J 1975; 267
- Seda H., Cardozo P. C. Eficácia e tolerabilidade do diclofenac sódico versus ibuprofen em portadores de osteoartrose. Folha Méd. (Rio de Janeiro) 1976; 72: 633
- Shiokawa Y., Takatori M., Sakuma A. [Multicentre trial of Voltaren (GP 45,840) in rheumatoid arthritis by double-blind technique]. Ryumachi 1972; 12: 271
- Steinbrocker O., Traeger C. H., Batterman R. C. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659
- Uthgenannt H., Timm H. Über den Einfluss von Voltaren auf die gastrointestinale Blutausscheidung. Therapiewoche 1976; 26: 2988
- Ziel R., Krupp P. The significance of inhibition of prostaglandin synthesis in the selection of nonsteroidal anti-inflammatory agents. Int J Clin Pharmacol 1975; 12: 186